|
|
Previous Article | Table of Contents | Next Article 
The effect of erythroid hyperplasia on iron balance
P Pootrakul, K Kitcharoen, P Yansukon, P Wasi, S Fucharoen, P Charoenlarp, G Brittenham, MJ Pippard and CA Finch
Department of Medicine, Siriraj Hospital, Bangkok, Thailand.
Measurements of erythropoiesis and iron balance were made in eight normal
and 32 anemic subjects. The latter consisted of 12 individuals with
ineffective erythropoiesis (beta-thalassemia/hemoglobin E), 13 subjects
with ineffective erythropoiesis and hemolytic anemia (hemoglobin H), and
seven subjects with hemolytic anemia (hereditary spherocytosis). A
consistent relationship within each group existed between the degree of
erythropoiesis and radioiron absorption. Although the effect of
erythropoiesis on iron absorption was of similar magnitude in the two
thalassemia groups, the effect in hereditary spherocytosis was much less.
There was agreement between absorption and ferritin or magnetic
susceptibility (SQUID) measurements of iron stores in thalassemia, but in
hereditary spherocytosis a discrepancy existed between absorption and
ferritin. It is concluded that, although increased erythropoiesis is
associated with increased iron absorption, some additional factor
associated with red cell breakdown is more directly responsible for the
positive iron balance in thalassemia.
Volume 71,
Issue 4,
pp. 1124-1129,
04/01/1988
Copyright © 1988 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Cazzola, M. G. Della Porta, and L. Malcovati
Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes
Hematology,
January 1, 2008;
2008(1):
166 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Origa, R. Galanello, T. Ganz, N. Giagu, L. Maccioni, G. Faa, and E. Nemeth
Liver iron concentrations and urinary hepcidin in {beta}-thalassemia
Haematologica,
May 1, 2007;
92(5):
583 - 588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Swinkels, M. C.H. Janssen, J. Bergmans, and J. J.M. Marx
Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
Clin. Chem.,
June 1, 2006;
52(6):
950 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Kushner, J. P. Porter, and N. F. Olivieri
Secondary Iron Overload
Hematology,
January 1, 2001;
2001(1):
47 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Goodnough, B. Skikne, and C. Brugnara
Erythropoietin, iron, and erythropoiesis
Blood,
August 1, 2000;
96(3):
823 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. F. Olivieri
The {beta}-Thalassemias
N. Engl. J. Med.,
July 8, 1999;
341(2):
99 - 109.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Moyo, E. Mandishona, S. J. Hasstedt, I. T. Gangaidzo, Z. A.R. Gomo, H. Khumalo, T. Saungweme, C. F. Kiire, A. C. Paterson, P. Bloom, et al.
Evidence of Genetic Transmission in African Iron Overload
Blood,
February 1, 1998;
91(3):
1076 - 1082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Rivkin, G. Link, E. Simhon, R. L. Cyjon, J. Y. Klein, and C. Hershko
IRC011, a New Synthetic Chelator With Selective Interaction With Catabolic Red Blood Cell Iron: Evaluation in Hypertransfused Rats With Hepatocellular and Reticuloendothelial Radioiron Probes and in Iron-Loaded Rat Heart Cells in Culture
Blood,
November 15, 1997;
90(10):
4180 - 4187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. F. Olivieri and G. M. Brittenham
Iron-Chelating Therapy and the Treatment of Thalassemia
Blood,
February 1, 1997;
89(3):
739 - 761.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Weiss, T. Houston, S. Kastner, K. Johrer, K. Grunewald, and J. H. Brock
Regulation of Cellular Iron Metabolism by Erythropoietin: Activation of Iron-Regulatory Protein and Upregulation of Transferrin Receptor Expression in Erythroid Cells
Blood,
January 15, 1997;
89(2):
680 - 687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Brittenham, P. M. Griffith, A. W. Nienhuis, C. E. McLaren, N. S. Young, E. E. Tucker, C. J. Allen, D. E. Farrell, and J. W. Harris
Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major
N. Engl. J. Med.,
September 1, 1994;
331(9):
567 - 573.
[Abstract]
[Full Text]
|
 |
|
|
|